ADVERTISEMENT
ADVERTISEMENT
pembrolizumab
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 16, 2018 | 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
ADVERTISEMENT